(R)-4-Isopropyl-5,5-diphenyloxazolidin-2-one, 95.0%, 1g

5-bromo-1-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-6-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione, 95.0%, 1g

8-Bromo-quinoline, 97.00%, 25g

4-Bromo-2,6-difluorobenzaldehyde, 97.0%, 25g

Lenalidomide, 96.00%, 1g

(R)-3-Methyl-pyrrolidine hydrochloride, 97.0%, 500mg

Confezione in vetro da 50 ml di olio essenziale di noce moscata

4,4'-Dihydroxybiphenyl, 95.0%, 1kg

(3-methyl-2-oxo-3,4-dihydroquinazolin-1(2H)-yl)acetic acid, 95.0%, 1g

1,4-Diphenoxybenzene, 95.0%, 5g

4,4'-(9H-carbazole-3,6-diyl)dibenzoic acid, 95%, 1g

tert-Butyl 4-(2-cyanoacetyl)piperidine-1-carboxylate, 95.0%, 1g

N'-(5,7-dimethyl-1,3-benzothiazol-2-yl)-N,N-diethylethane-1,2-diamine, 95.0%, 250mg